Skip to content
sellModerate

Deep Track Biotechnology Master Fund, Ltd. sold $22M of DVAX

owner at DYNAVAX TECHNOLOGIES CORP. 2,065,137 shares at an average of $10.82, traded Aug 21, 2025, filed Aug 22, 2025.

Warning score
42
Value
$22M
2,065,137 shares
Holdings after
15,726,349
-12% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    10% owner
    +12
  • Trade size
    $22.4M at market
    +25
  • Share of holdings sold
    Sold 12% of holdings
    +5
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0000950170-25-111070, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 21, 2025SOpen-market sale
Common Stock, par value $0.001 per share
-1,094,994$11.03$12M16,696,492Aug 22, 2025
Aug 22, 2025SOpen-market sale
Common Stock, par value $0.001 per share
-970,143$10.59$10M15,726,349Aug 22, 2025

Related signals

Other insiders at DYNAVAX TECHNOLOGIES CORP and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
24Weak
DVAXbuy
DYNAVAX TECHNOLOGIES CORP
Scott Dunseth Myers
director
$41k
3,800 shares
+12%
16Weak
DVAXsell10b5-1
DYNAVAX TECHNOLOGIES CORP
David F Novack
President & COO
$140k
10,000 shares
-55%
32Weak
DVAXsell10b5-1
DYNAVAX TECHNOLOGIES CORP
David F Novack
President & COO
$190k
14,020 shares
-63%
37Weak
DVAXsell10b5-1
DYNAVAX TECHNOLOGIES CORP
David F Novack
President & COO
$471k
32,764 shares
-60%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Deep Track Biotechnology Master Fund, Ltd. sold $22M of DVAX | InsiderTell